Nektar Therapeutics (NKTR) Insider Trading
- $1,135,850.00
- $232,639,248.75
- Dec. 19, 2024
- Howard W Robin
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 19, 2024 | Insider | 51,115 | $0.94 | Sell | $48,048.10 | |
Dec. 17, 2024 | CEO | 46,995 | $1.01 | Sell | $47,464.95 | |
Nov. 19, 2024 | CEO | 16,278 | $1.01 | Sell | $16,440.78 | |
Nov. 19, 2024 | Insider | 7,785 | $1.01 | Sell | $7,862.85 | |
Aug. 19, 2024 | Insider | 6,866 | $1.28 | Sell | $8,788.48 | |
Aug. 19, 2024 | CEO | 14,881 | $1.28 | Sell | $19,047.68 | |
June 14, 2024 | Director | 19,500 | $1.20 | Sell | $23,400.00 | |
May 17, 2024 | CEO | 16,650 | $1.75 | Sell | $29,137.50 | |
May 17, 2024 | Insider | 7,355 | $1.75 | Sell | $12,871.25 | |
May 10, 2024 | Major Shareholder | 56,000 | $1.78 | Sell | $99,680.00 | |
Feb. 20, 2024 | CEO | 20,033 | $0.68 | Sell | $13,622.44 | |
Feb. 20, 2024 | Insider | 9,014 | $0.68 | Sell | $6,129.52 | |
Nov. 17, 2023 | CEO | 19,877 | $0.49 | Sell | $9,739.73 | |
Nov. 17, 2023 | Insider | 9,646 | $0.49 | Sell | $4,726.54 | |
Sept. 18, 2023 | Director | 4,359 | $0.69 | Sell | $3,007.71 | |
Aug. 16, 2023 | Insider | 9,703 | $0.78 | Sell | $7,568.34 | |
Aug. 16, 2023 | CEO | 19,998 | $0.78 | Sell | $15,598.44 | |
June 14, 2023 | Director | 30,000 | $0.57 | Sell | $17,100.00 | |
May 16, 2023 | CEO | 20,361 | $0.72 | Sell | $14,659.92 | |
May 16, 2023 | Insider | 9,791 | $0.72 | Sell | $7,049.52 | |
Feb. 16, 2023 | Insider | 10,484 | $3.00 | Sell | $31,452.00 | |
Feb. 16, 2023 | CFO | 10,267 | $3.00 | Sell | $30,801.00 | |
Feb. 16, 2023 | CEO | 19,635 | $3.00 | Sell | $58,905.00 | |
Nov. 16, 2022 | CFO | 11,095 | $3.57 | Sell | $39,609.15 | |
Nov. 16, 2022 | CEO | 38,014 | $3.57 | Sell | $135,709.98 | |
Nov. 16, 2022 | Insider | 13,460 | $3.57 | Sell | $48,052.20 | |
Sept. 23, 2022 | Director | 4,198 | $3.16 | Sell | $13,265.68 | |
Sept. 13, 2022 | Director | 21,267 | $3.61 | Sell | $76,773.87 | |
Aug. 18, 2022 | Insider | 73,716 | $4.65 | Sell | $342,779.40 | |
Aug. 16, 2022 | CEO | 13,759 | $4.76 | Sell | $65,492.84 | |
Aug. 16, 2022 | Insider | 10,560 | $4.76 | Sell | $50,265.60 | |
Aug. 16, 2022 | CAO | 2,006 | $4.76 | Sell | $9,548.56 | |
Aug. 16, 2022 | SVP | 3,189 | $4.76 | Sell | $15,179.64 | |
May 16, 2022 | CFO | 17,448 | $3.95 | Sell | $68,919.60 | |
May 16, 2022 | CAO | 5,841 | $3.95 | Sell | $23,071.95 | |
May 16, 2022 | SVP | 3,136 | $3.95 | Sell | $12,387.20 | |
May 16, 2022 | CEO | 36,529 | $3.95 | Sell | $144,289.55 | |
May 16, 2022 | Insider | 21,673 | $3.95 | Sell | $85,608.35 | |
Feb. 16, 2022 | CEO | 12,480 | $10.95 | Sell | $136,656.00 | |
Feb. 16, 2022 | Insider | 10,912 | $10.95 | Sell | $119,486.40 | |
Feb. 16, 2022 | CAO | 2,363 | $10.95 | Sell | $25,874.85 | |
Feb. 16, 2022 | SVP | 4,852 | $10.95 | Sell | $53,129.40 | |
Feb. 16, 2022 | CFO | 7,579 | $10.95 | Sell | $82,990.05 | |
Nov. 18, 2021 | CFO | 3,000 | $12.69 | Sell | $38,070.00 | |
Nov. 16, 2021 | CFO | 21,149 | $13.16 | Sell | $278,320.84 | |
Sept. 22, 2021 | Director | 3,665 | $17.78 | Sell | $65,163.70 | |
Sept. 8, 2021 | Director | 8,000 | $16.00 | Sell | $128,000.00 | |
Aug. 16, 2021 | CFO | 7,867 | $13.83 | Sell | $108,800.61 | |
Aug. 16, 2021 | CEO | 11,515 | $13.83 | Sell | $159,252.45 | |
Aug. 16, 2021 | SVP | 1,910 | $13.83 | Sell | $26,415.30 |
Insiders are both buying and selling Nektar Therapeutics stock.
The insider traders at Nektar Therapeutics are: Howard W Robin, Gil M. Labrucherie, Jillian B. Thomsen, Robert Chess, Jonathan Zalevsky, John Nicholson, Gil M Labrucherie, Howard W. Robin, Stephen K Doberstein, Jillian B Thomsen, Lutz Lingnau, Mark Andrew Wilson, Ivan P Gergel, Maninder Hora, Jeffrey Robert Ajer, R Scott Greer, Dennis L Winger, Christopher A Kuebler, Myriam Curet, Susan Wang, Christopher A. Kuebler, Roy A Whitfield, Karin Eastham, Curet Myriam, Roy Whitfield, John Northcott, Deep Track Capital, Lp, Stephen K. Doberstein, and Katharina Otto-Bernstein
The most active insider trader at Nektar Therapeutics is Howard W Robin with 50 trades.
Howard W Robin has sold the most Nektar Therapeutics stock with a total value of $84,364,729.40.
Roy A Whitfield has bought the most Nektar Therapeutics stock with a total value of $1,256,500.00.
The most recent insider trade for Nektar Therapeutics was on Dec. 19, 2024.
The single biggest insider buy for Nektar Therapeutics was from Roy A Whitfield with a total value of $628,250.00 on Aug. 10, 2017.
The single biggest insider sell for Nektar Therapeutics was from John Nicholson with a total value of $21,853,694.88 on March 7, 2018.